HU206975B - Process for producing granulation and veterinary composition comprising water-soluble flumequine complex - Google Patents

Process for producing granulation and veterinary composition comprising water-soluble flumequine complex

Info

Publication number
HU206975B
HU206975B HU84191A HU84191A HU206975B HU 206975 B HU206975 B HU 206975B HU 84191 A HU84191 A HU 84191A HU 84191 A HU84191 A HU 84191A HU 206975 B HU206975 B HU 206975B
Authority
HU
Hungary
Prior art keywords
flumequine
soluble
complex
water
veterinary composition
Prior art date
Application number
HU84191A
Other languages
English (en)
Other versions
HU910841D0 (en
Inventor
Istvan Hutas
Dr Marton Andrea Haszmann-Ne
Zoltan Bende
Ferenc Pribek
Laszlo Nagy
Original Assignee
Reanal Finomvegyszergyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reanal Finomvegyszergyar filed Critical Reanal Finomvegyszergyar
Priority to HU84191A priority Critical patent/HU206975B/hu
Publication of HU910841D0 publication Critical patent/HU910841D0/hu
Priority to EP19920906850 priority patent/EP0575439A1/en
Priority to PCT/HU1992/000013 priority patent/WO1992016209A1/en
Publication of HU206975B publication Critical patent/HU206975B/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU84191A 1991-03-14 1991-03-14 Process for producing granulation and veterinary composition comprising water-soluble flumequine complex HU206975B (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
HU84191A HU206975B (en) 1991-03-14 1991-03-14 Process for producing granulation and veterinary composition comprising water-soluble flumequine complex
EP19920906850 EP0575439A1 (en) 1991-03-14 1992-03-13 Granules and veterinary compositions comprising a water-soluble complex of flumequine
PCT/HU1992/000013 WO1992016209A1 (en) 1991-03-14 1992-03-13 Granules and veterinary compositions comprising a water-soluble complex of flumequine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU84191A HU206975B (en) 1991-03-14 1991-03-14 Process for producing granulation and veterinary composition comprising water-soluble flumequine complex

Publications (2)

Publication Number Publication Date
HU910841D0 HU910841D0 (en) 1991-09-30
HU206975B true HU206975B (en) 1993-03-01

Family

ID=10951644

Family Applications (1)

Application Number Title Priority Date Filing Date
HU84191A HU206975B (en) 1991-03-14 1991-03-14 Process for producing granulation and veterinary composition comprising water-soluble flumequine complex

Country Status (3)

Country Link
EP (1) EP0575439A1 (hu)
HU (1) HU206975B (hu)
WO (1) WO1992016209A1 (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9517883D0 (en) * 1995-09-01 1995-11-01 Euro Celtique Sa Improved pharmaceutical ion exchange resin composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1111918B (it) * 1979-04-10 1986-01-13 Riker Laboratories Inc Medicamento veterinario a base di acidi benzochinolizin carbossilici e loro derivati
NO832446L (no) * 1982-07-06 1984-01-30 Sterwin Ag, Fremgangsmaate ved fremstilling av tabletter.
NZ214495A (en) * 1985-12-10 1988-02-12 Erik Audunn Cerwen Formation of polar-nonpolar-polar proteolipid membranes
US4889862A (en) * 1986-08-28 1989-12-26 E. I. Du Pont De Nemours And Company Freeze-dried pharmaceutical compositions of phenylquinoline carboxylic acids
US4900775A (en) * 1988-02-29 1990-02-13 Gaf Chemicals Corporation Solubilization of complexes of water-insoluble organic compounds by aqueous solutions of polyvinylpyrrolidone

Also Published As

Publication number Publication date
EP0575439A1 (en) 1993-12-29
WO1992016209A1 (en) 1992-10-01
HU910841D0 (en) 1991-09-30

Similar Documents

Publication Publication Date Title
HU912755D0 (en) Water-soluble taxole derivatives and process for producing said compounds
HU9400413D0 (en) Imidazoly-alcenoic acids, pharmaceutical compositions containing them, and process for producing them
HUT56565A (en) Process for producing 3-arylcarbonyl-1h-indole derivatives and pharmaceutical compositions comprising same
HUT63632A (en) Process for producing 5-amino-4-hydroxyhexanoic acid derivatives and pharmaceutical compositions comprising same
HUT50046A (en) Process for producing pharmaceutical compositions with controlled release and comprising tetracycline compounds
AU2846492A (en) Process for preparing sintered shapes and compositions used therein
HUT59390A (en) Process for producing quinazoline derivatives and pharmaceutical compositions comprising same
HUT53362A (en) Process for producing substituted 1,3-oxathiolans and pharmaceutical compositions comprising same
EP0451442A3 (en) Methylene-crosslinked polyarylamine and process for preparing same
HUT63628A (en) Process for producing new cefalosporing derivatives and pharmaceutical compositions comprising same
HUT54139A (en) Process for producing n-heteroaryl-4-quinolineamine derivatives and pharmaceutical compositions comprising such compounds
HUT63602A (en) Process for producing carboxylic acid derivatives and compositions comprising same
HUT54112A (en) Process for producing benzocycloalkane derivatives and pharmaceutical compositions comprising same
CS9892A3 (en) Boron compounds and process for preparing thereof
HU9303171D0 (en) Pharmaceutical compositions for preventing and treating tumouric illnesses and process for preparing them
EP0463833A3 (en) Controlled release pharmaceutical preparation and process for preparing same
IL103790A0 (en) Process for preparing sintered shapes and compositions for use therein
HUT50829A (en) Process for producing thienoazepines and pharmaceutical compositions comprising same
HU9200008D0 (en) Phenoxi-alkyl-carboxylic acid and process for producing it
NZ234098A (en) A veterinary composition comprising a synthetic fsh and method of preparation of a molecular clone therefor
HUT53620A (en) Process for producing new thiouracyl derivatives and pharmaceutical compositions comprising same
HU206975B (en) Process for producing granulation and veterinary composition comprising water-soluble flumequine complex
GR900100491A (en) Acaricidel compositions and process for preparing same
OA09959A (en) Process for preparing 3-acylestratrienes and acylbenzenes
GB9324145D0 (en) Encapsulated acid composition and process for preparing and using same

Legal Events

Date Code Title Description
HPC4 Succession in title of patentee

Owner name: PENTAREX GYARTO ES KERESKEDELMI BT., HU

Owner name: EUROPHARMA KERESKEDELMI, FEJLESZTOE ES SZOLGALTATO

HMM4 Cancellation of final prot. due to non-payment of fee